Onesource Specialty Pharma Limited (ONESOURCE) — Announcement | 27 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Preeti Kalra appointed as SMP; Ravi Kumar resigns effective July 24, 2026
💡 Investor Takeaway
The leadership reshuffle may affect execution of the company's strategic initiatives.

On July 24, 2026, OneSource Specialty Pharma announced that Preeti Kalra was appointed as a Senior Management Personnel effective that date, while Ravi Kumar resigned from his role as Global Head of Injectables and Head of Corporate Strategy effective close of business on the same day. The changes were disclosed under SEBI Listing Regulations, with Ravi Kumar's resignation letter filed as Annexure 3.

📄 View Original Announcement (PDF)

About Onesource Specialty Pharma Limited (ONESOURCE)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹17,366.55 Cr ROE: -0.8% ROCE: 0.9%

View full ONESOURCE stock details →

📡 Get AI alerts when ONESOURCE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ONESOURCE — Free

📊 More ONESOURCE filings

See all ONESOURCE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ONESOURCE files new disclosures

Track ONESOURCE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ONESOURCE — Free

Free account · 2 AI queries/day